Brain Tunnelgenix Technologies Corp. won Food & Drug Administration 510(k) clearance for its body temperature sensor system.
The Hamden, Conn.-based biotech firm said its Abreu BTT 700 system is indicated for placement on the skin during surgical procedures and in the recovery room and intensive care unit to continuously monitor a patient’s body temperature.
The devices’ sensor is attached to the area of the skin between the eye and eyebrow, which has highest thermoconductivity on the body, according to BTT Corp. The company calls the area of the body underneath this section of skin the "brain temperature tunnel," a phrase which the company trademarked.
BTT Corp., which was founded by Yale University School of Medicine professor Dr. Marc Abreu, began a $6 million funding round in April, shortly after submitting its 510(k) application for Abreu’s namesake device.
The company said it plans to launch the product in October.
